New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma-Reference-Cited by-同舟云学术

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Published:2011-08-11 Issue:6 Volume:118 Page:1486-1497
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Agulnik Mark¹

Affiliation:

1. Division of Medical Hematology/Oncology, Northwestern University, Chicago, Illinois

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.26361

Reference107 articles.

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™: Soft Tissue Sarcoma Version 1.2011.http://www.nccn.org. Accessed February 8 2011.

2. Surveillance Epidemiology and End Results Program. SEER Stat Fact Sheet: Soft Tissue Including Heart.http://seer.cancer.gov/statfacts/html/soft.html. Accessed November 22 2010.

3. Surveillance Epidemiology and End Results Program. SEER Stat Fact Sheet: Bone and Joint.http://seer.cancer.gov/statfacts/html/bones.html. Accessed November 22 2010.

4. Targeting Sarcomas: Novel Biological Agents and Future Perspectives

5. mTOR inhibitors in the treatment of cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance;Frontiers in Oral Health;2021-01-25

2. Expression and Clinical Significance of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and a Disintegrin and Metalloproteinase with Thrombospondin Type 1 Motif 1 (ADAMTS1) in Post-Kidney-Transplant Bladder Tumors;Annals of Transplantation;2017-10-17

3. Chronic mTOR Inhibition by Rapamycin and Diabetes;Molecules to Medicine with mTOR;2016

4. Potential Future Indication of Rapamycin Analogs for the Treatment of Solid Tumors;mTOR Inhibition for Cancer Therapy: Past, Present and Future;2016

5. KANSER TEDAVİSİNDE mTOR İNHİBİTÖRLERİ;MARMARA PHARMACEUTCAL JOURNAL;2015-04-20